10. De-resuscitation & Fluid Overload Management

Quick Recap

Renal System, new protocol. Companion to Timing of Renal Replacement Therapy Initiation and Acute Kidney Injury (both Renal System) — addresses the phase after initial resuscitation, when accumulated fluid itself becomes a potential harm requiring active management, with a genuinely important gap between fluid overload's clear association with mortality and the much less certain evidence that actively reversing it improves survival.

1. Definition

De-resuscitation: the active removal of accumulated fluid (via diuretics or ultrafiltration) once the acute shock/resuscitation phase has resolved — distinct from simply restricting fluid intake going forward. Fluid overload is common in critical illness and is consistently associated with mortality in observational data — the motivating rationale for de-resuscitation as an active strategy, not just passive fluid restriction.

2. A Genuine, Important Gap — Association Is Clear, Causation Is Not

This protocol treats the distinction between "fluid overload correlates with worse outcomes" (well-established) and "actively reversing fluid overload improves survival" (genuinely unproven) as the central issue requiring honest handling:

• Messmer et al., systematic review and meta-analysis (2023): active fluid de-resuscitation in septic shock had no mortality benefit or impact on patient-centered outcomes — explicitly limited by small, heterogeneous RCTs and inconsistent separation of fluid balance between study arms
• Despite restrictive fluid regimens undergoing "thorough investigation," no large RCT has been able to demonstrate superiority of a restrictive fluid management strategy regarding ICU survival — a direct, honest acknowledgment from the recent literature itself
• The FFAKI pilot trial (forced fluid removal via RRT vs. standard care in patients at AKI risk with fluid accumulation) had to be stopped prematurely due to recruitment issues, leaving only 20 patients analyzed — no reliable conclusion on mortality or other secondary outcomes can be drawn from this trial

Practical implication: this protocol does not claim active de-resuscitation is a proven, mortality-reducing intervention — fluid overload is a genuine marker of illness severity and probably contributes to organ dysfunction, but the RCT-level evidence that actively reversing it changes survival remains genuinely unestablished.

3. A Specific, Important Harm Signal — Timing and Population Matter

The RADAR-2 trial (feasibility RCT, conservative fluid administration plus active de-resuscitation vs. usual care): a secondary analysis found the intervention did not adversely affect tissue perfusion or kidney injury markers, and was associated with reduced vascular injury markers compared with usual care — a reassuring safety signal on the mechanistic/biomarker level.

However, a specific subgroup analysis within RADAR-2 found that active de-resuscitation performed early (within 24-48 hours of ICU admission) could INCREASE mortality risk specifically in mechanically ventilated patients with sepsis — a genuinely important, population- and timing-specific caution this protocol treats seriously. This directly argues against a blanket "de-resuscitate everyone with fluid overload as early as possible" approach, and instead supports individualizing both the timing and the specific population in whom active de-resuscitation is attempted.

Supporting evidence for individualization: the REDUCE trial (restrictive fluid management with early de-escalation, Thailand, 2022-2024) found AKI and other serious adverse events were similar between groups, but the investigators' own conclusion explicitly states this "highlights the need to individualize active de-resuscitation" rather than applying it uniformly.

4. Ultrafiltration Rate — A Genuine, Specific Caution

A retrospective analysis of the RENAL trial (normal vs. augmented RRT intensity) found every 1mL/kg/h increase in ultrafiltration rate was associated with a LOWER probability of kidney recovery and a longer time to RRT independence — a genuinely important, specific caution for patients already on CRRT: aggressive ultrafiltration to achieve fluid removal quickly may come at the cost of delayed renal recovery, a real tradeoff to weigh rather than simply maximizing UF rate to clear fluid faster.

A practical de-resuscitation protocol worth knowing: the EARLY-DRY study implemented a perfusion-based de-resuscitation protocol guiding fluid removal during CRRT once circulatory failure had resolved, using a binary fluid overload threshold (>5%) to identify patients who should undergo active de-resuscitation — illustrating one structured, physiology-guided (not simply time-triggered) approach to deciding who and when to de-resuscitate.

5. Diuretic Response — What Predicts Success

A large retrospective cohort study (1,764 patients, 6,632 ICU days) examining IV furosemide response found mean arterial pressure was the strongest predictor of achieving negative fluid balance after the first diuretic dose — a practical, useful bedside indicator: hemodynamically stable patients with adequate MAP are more likely to successfully diurese, informing which patients are good de-resuscitation candidates versus those needing further hemodynamic optimization first.

A related, genuinely counterintuitive cardiac surgery finding: early administration of IV diuretics (within the first 24 hours) was NOT associated with a lower risk of AKI progression in a large post-cardiac-surgery cohort — reinforcing that reflexive early diuresis, absent a specific fluid-overload indication, does not appear to be independently protective.

6. Practical Synthesis

1. Recognize fluid overload as a genuine marker of severity and a plausible contributor to organ dysfunction, but do not assume active de-resuscitation is a proven, mortality-reducing intervention — current RCT evidence does not establish this
2. Individualize timing and population — avoid routine, early (24-48h) active de-resuscitation specifically in mechanically ventilated septic patients, given RADAR-2's subgroup harm signal
3. Use a physiology-guided trigger (e.g., a defined fluid overload threshold, as in EARLY-DRY) rather than a purely time-based or reflexive approach to initiating de-resuscitation
4. In patients on CRRT, avoid maximizing ultrafiltration rate purely to accelerate fluid removal — higher UF rates are associated with reduced renal recovery probability and prolonged RRT dependence
5. Assess hemodynamic stability (particularly MAP) before initiating diuresis — patients with adequate MAP are more likely to successfully achieve negative fluid balance
6. Don't reflexively start early diuretics as a preventive AKI strategy — the cardiac surgery cohort data found no protective association from this practice

7. Consultation Matrix

8. Documentation & Medicolegal Checklist

• Fluid balance trend and specific trigger for initiating de-resuscitation documented
• Hemodynamic status (MAP, vasopressor requirement) at time of de-resuscitation initiation documented
• Ultrafiltration rate and rationale, where CRRT is used for fluid removal, documented

9. Key Guidelines

• No single guideline mandates a specific de-resuscitation protocol; the "four D's of fluid therapy" framework (resuscitation, optimization, stabilization, de-escalation/de-resuscitation) provides a widely-referenced conceptual structure, though implementation specifics remain institution- and patient-specific

10. Landmark Evidence

11. Controversies

• The core, honestly-acknowledged gap in this protocol: fluid overload's association with mortality is well-established, but no large RCT has demonstrated that actively reversing it (de-resuscitation) improves survival — this protocol treats these as genuinely separate claims, consistent with this library's broader practice of not assuming a treatment for a marker of illness automatically improves the outcome that marker predicts.
• The RADAR-2 subgroup finding of increased mortality with early de-resuscitation in ventilated septic patients is a genuinely important, population-specific caution that argues against uniform, protocol-driven early de-resuscitation — this protocol treats individualization (per REDUCE's own stated conclusion) as the current appropriate response to this uncertainty, not a specific universal timing rule.
• Ultrafiltration rate optimization during CRRT-based de-resuscitation involves a genuine tradeoff (faster fluid removal vs. renal recovery probability) that current evidence does not fully resolve into a single optimal rate — individualized based on the patient's specific fluid overload severity and hemodynamic tolerance.

12. References

1. Silversides JA, McMullan R, Emerson LM, et al. Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial. Intensive Care Med. 2022;48(2):190-200.
2. The Effects of Conservative Fluid Management and Active Deresuscitation on Markers of Tissue Perfusion, Kidney Injury, and Vascular Injury: A Secondary Analysis of RADAR-2. Crit Care Med.
3. Messmer AS, Dill T, Müller M, et al. Active fluid de-resuscitation in critically ill patients with septic shock: a systematic review and meta-analysis. Eur J Intern Med. 2023;109:89-96.
4. Restrictive fluid management with early de-escalation versus usual care in critically ill patients (REDUCE trial): a feasibility randomized controlled trial. 2025.
5. Ruste M, et al. EARLY-DRY Study: perfusion-based de-resuscitation protocol during CRRT.
6. RENAL Trial Investigators. Intensity of continuous renal-replacement therapy in critically ill patients (retrospective UF rate analysis).
7. Clinical Parameters Associated with Achieving Negative Fluid Balance in Critically Ill Patients: A Retrospective Cohort Study. 2025.
8. Fluid de-resuscitation in critical illness – A journey into uncertain territory [editorial]. J Crit Care. 2023.
9. Malbrain MLNG, Van Regenmortel N, Saugel B, et al. Principles of fluid management and stewardship in septic shock: it is time to consider the four D's and the four phases of fluid therapy.

See also: Timing of Renal Replacement Therapy Initiation and Acute Kidney Injury (Renal System) for the broader RRT decision framework; Balanced Crystalloids vs. Saline (Miscellaneous Topics) for the initial resuscitation fluid choice; Cardiogenic Shock and Vasopressor & Inotrope Selection & Titration (Cardiovascular System) for the earlier resuscitation-phase management this protocol picks up after.